[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-390708-105":59,"doc-detail-390708-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","addressing-high-rates-of-stis-updated-clinical-guidelines-to-testing-treatment-with-prep-pep-care","Addressing High Rates of STIs - Updated Clinical Guidelines to Testing & Treatment - With PrEP & PEP Care","","Webinar content presents updated clinical guidance on STI testing and treatment through an evidence-based prevention framework integrating PrEP and PEP care. It outlines the presenter’s expertise in HIV prevention and describes targeted learning objectives for identifying priority patient groups for STI testing, matching screening and treatment methods to key populations, and emphasizing the value of STI care for women and pregnant people. Supporting CDC surveillance data highlights rising chlamydia, gonorrhea, and syphilis patterns by age, sex, race/ethnicity, and partner demographics.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/addressing-high-rates-of-stis-updated-clinical-guidelines-to-testing-treatment-with-prep-pep-care/390708/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/addressing-high-rates-of-stis-updated-clinical-guidelines-to-testing-treatment-with-prep-pep-care/390708.png","ImageObject",300,407,{"name":92,"@type":93},"\tCallum ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-25",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the webinar’s main focus on STI care?","Question",{"text":112,"@type":113},"The webinar focuses on updated clinical guidelines for STI testing and treatment, integrated with PrEP and PEP prevention care.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which groups does the training emphasize for STI testing?",{"text":117,"@type":113},"Participants are guided to identify key groups that benefit most from STI disease testing, including guidance that highlights women and pregnant people.",{"name":119,"@type":110,"acceptedAnswer":120},"What data sources support the webinar’s key findings?",{"text":121,"@type":113},"The session references CDC Sexually Transmitted Disease Surveillance 2021 to describe reported STI rates and patterns by age, sex, and race/ethnicity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},390708,1790625091,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},137451211410,"https://ap-avatar.wpscdn.com/avatar/2000bb0a9246f588df?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786362646172706240","Presenter Dr. Alicia Morehead-Gee  \nAlicia Morehead-Gee, MD, MS, graduated from Charles Drew/UCLA Medical Education Program. Following that, she trained in the UCSF Internal Medicine San Francisco Primary Care (SFPC) Residency Program, where she first began her interest in HIV prevention. Dr. Morehead-Gee was a National Clinician Scholar at UCLA from 2018 to 2020, focusing on HIV prevention research to decrease racial/ethnic disparities in PrEP use. Her goal is to continue developing programs that improve healthcare experiences and health outcomes for patients of various marginalized backgrounds.  \nDr. Alicia Morehead-Gee is a general internal medicine physician and health services leader committed to designing solutions to improve health outcomes among underserved populations. As Medical Director of HIV Prevention at AltaMed Health Services Corporation, she leads an initiative to expand access to HIV preventive care by finding new avenues to deliver HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) . This involves teaching primary care providers, pharmacists, and healthcare staff about HIV prevention, sexual health, and LGBTQ+ inclusive care.  \nAddressing High Rates of STIs:  \nUpdated Clinical Guidelines to Testing & Treatment  \nAlicia Morehead-Gee, MD, MS Medical Director, HIV Prevention AltaMed Health Services  \nMay 5, 2023 Live Webinar, 12:00 pm – 1:00 pm PST, 1 CME/CE Credit Directly Provided CME/CE Activity by L.A. Care Health Plan  \nWith PrEP &PEP Care  \nDisclosures  \nThe following CME planners and faculty do not have any financial relationships with ineligible companies in the past 24 months:  \n• Leilanie Mercurio, L.A. Care PCE Program Manager, CME Planner  \n• Johanna Gonzalez, L.A. Care QI Project Manager, CME Planner  \n• Brigitte Bailey, L.A. Care QI Program Manager, CME Planner  \n• Alicia Morehead-Gee, MD, MS, Medical Director, HIV Prevention, AltaMed Health Services, CME Faculty  \nAn ineligible company is any entity whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.  \nCommercial support was not received for this CME activity.  \nDr. Alicia Morehead-Gee’s work is funded by the California Department of Public Health, Office of AIDS Project Empowerment Grant.  \nLearning Objectives  \n• At the completion of the CME/CE activity, webinar participants/learners can:  \n• Identify key groups that benefit most from sexually transmitted infectious (STI) disease testing.  \n• Name STI screening and treatment methods for key groups.  \n• Summarize the importance of STI testing and treatment for women and pregnant people.  \n• Specify prevention methods for STIs.  \nWith PrEP &PEP Care  \nCenters for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2021. Atlanta: U.S. Department of Health and Human Services; 2023.  \nWith PrEP &PEP Care  \n5  \nChlamydia –Affecting girls & women aged 15-29 the most  \nRates of Reported Cases by Age Group & Sex, United States, 2021  \n* Per 100,000  \nNOTE: Total includes all ages.  \nCenters for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2021. Atlanta: U.S. Department of Health and Human Services; 2023.  \nWith PrEP &PEP Care  \n6  \nChlamydia is also affecting marginalized groups  \nRates of Reported Cases by Race/Ethnicity, U.S. , 2017–2021  \n* Per 100,000  \nAcronyms:  \n• Black/AA = Black or African American  \n• AI/AN = American Indian or Alaska Native  \n• NH/PI = Native Hawaiian or other Pacific Islander  \nCenters for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2021. Atlanta: U.S. Department of Health and Human Services; 2023.  \nWith PrEP &PEP Care  \n7  \nGonorrhea – Affecting males & females aged 15 – 29  \nRates of Reported Cases by Age Group & Sex,  \nU.S. , 2021  \nRate of Reported Cases by Race/Ethnicity & Sex, U.S. , 2021  \nCenters for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2021. Atlanta: U.S","cbCaivPelH1KRtwo","https://ap.wps.com/l/cbCaivPelH1KRtwo","pdf",3103871,45,"English","# Addressing High Rates of STIs\n## Updated Clinical Guidelines to Testing & Treatment\n## Learning Objectives\n## Key STI Surveillance Findings","[{\"question\":\"What is the webinar’s main focus on STI care?\",\"answer\":\"The webinar focuses on updated clinical guidelines for STI testing and treatment, integrated with PrEP and PEP prevention care.\"},{\"question\":\"Which groups does the training emphasize for STI testing?\",\"answer\":\"Participants are guided to identify key groups that benefit most from STI disease testing, including guidance that highlights women and pregnant people.\"},{\"question\":\"What data sources support the webinar’s key findings?\",\"answer\":\"The session references CDC Sexually Transmitted Disease Surveillance 2021 to describe reported STI rates and patterns by age, sex, and race/ethnicity.\"}]","Addressing High Rates of STIs - Updated Clinical Guidelines to Testing & Treatment - With PrEP & PEP Care | PDF",1790338464,113]